ArticleVeterinary medicine and science2026
In Vitro Evaluation of Antileishmanial Activity of Commiphora myrrha Essential Oil Nanoliposome.
Article in Veterinary medicine and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectiveLeishmaniasis poses a significant public health challenge worldwide. Nanotechnology has emerged as a promising avenue in parasitology, offering novel strategies for diagnosing, treating, and preventing diseases like leishmaniasis. Hence, the current study investigates the in vitro efficacy of nanoliposomal formulations containing Commiphora myrrha (C. myrrha) essential oil in combating Leishmania tropica (MHOM/IR/99/YAZ1).
methodsCommiphora myrrha essential oil and nanoliposomes were prepared in RPMI-1640 medium at concentrations of 1, 2, 5 and 10 µg/dL. Promastigotes were exposed to these compounds for 24 h, and viability was assessed using an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay.
resultsDynamic light scattering analysis revealed nanoliposomes of C. myrrha essential oil to be approximately 122.3 nm in size with a polydispersity index of 0.852, indicating nanoscale formulation and good particle dispersion. Significantly higher mortality rates were observed in promastigotes treated with nanoliposomes compared to those treated with C. myrrha essential oil alone (p < 0.005). Glucantime treatment demonstrated the highest mortality rate, significantly differing from C. myrrha essential oil and nanoliposome treatments (p < 0.001). The 50% lethal concentration (LC50) for C. myrrha essential oil nanoliposomes was determined to be 15.30 µg/mL (95% confidence interval: 10.70-28.04 µg/mL).
conclusionThe results of the present study are promising, suggesting that C. myrrha essential oil nanoliposomes could play a significant role in the fight against L. tropica. Further in vivo studies with different doses are recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.